Search for: "Anda Pharmaceuticals, Inc"
Results 461 - 480
of 607
Sort by Relevance
|
Sort by Date
10 May 2010, 10:37 am
Lupin Pharmaceuticals, Inc. [read post]
6 May 2010, 9:43 am
Teva Pharmaceuticals, USA, et al., 2009 WL 73274 (N.D.Ill. 03/16/09). [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
26 Apr 2010, 7:50 am
Mylan Pharmaceuticals, Inc., C.A. [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
19 Apr 2010, 1:34 pm
District Court for the District of Delaware’s recent decision in Millennium Pharmaceuticals, Inc. v. [read post]
19 Apr 2010, 5:23 am
" Millennium Pharmaceuticals Inc. et al v. [read post]
15 Apr 2010, 11:19 am
See Andrx Pharms., Inc. v. [read post]
15 Apr 2010, 7:04 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
11 Apr 2010, 9:36 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
4 Apr 2010, 9:55 pm
Endo Pharmaceuticals Inc. 1:10-cv-00261; filed March 31, 2010 in the District Court of Delaware Infringement of U.S. [read post]
19 Mar 2010, 8:49 am
Plaintiffs filed this patent infringement action against defendants Anchen Pharmaceuticals and Anchen Inc. after the defendants filed their Abbreviated New Drug Application (“ANDA”) to manufacture generic versions of AMRIX®. [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US: OGD’s… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US: OGD’s… [read post]
23 Feb 2010, 9:01 pm
By Suresh Pillai -- Lupin Claims Tri-Cyclen® Patent Invalid Lupin Pharmaceuticals Inc. has filed counterclaims in its suit with Ortho-McNeil-Janssen Pharmaceuticals Inc., alleging that Ortho's patent covering its Tri-Cyclen® Lo contraceptive, U.S. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
19 Jan 2010, 1:05 pm
Pfizer Inc. has filed a civil suit against the generic drug manufacturer Teva Pharmaceutical Industries Ltd. for infringement of US patent for antibiotic drug Zyvox. [read post]
